Clinical Trial Update: Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN) [Phase 3]

View source ↗

Summary

Phase 3 study to evaluate the efficacy and safety of N1087 in female pattern hair loss (MINORA-WOMEN); recruitment status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss

Drugs mentioned

• N1087

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia | Phase 3 | Status: NOT_YET_RECRUITING